Inovio Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Inovio Pharmaceuticals, Inc. To Contact The Firm

0
337

New York, New York–(Newsfile Corp. – April 4, 2020) – Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO) (“Inovio” or the “Company”) of the May 12, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.